Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia

Int J Hematol. 2008 Nov;88(4):441-442. doi: 10.1007/s12185-008-0172-6. Epub 2008 Oct 7.

Abstract

Veno-occlusive disease (VOD) of the liver, also termed as sinusoidal obstruction syndrome, constitutes a well-known complication of high-dose cytoreductive chemotherapy prior to allogeneic or autologous bone marrow transplantation and is associated with the intensity of treatment [1]. On the contrary, there is only one report of VOD during induction therapy for acute lymphoblastic leukemia in a patient with Marfan syndrome, who was successfully treated with defibrotide [2]. In this article, we present the first fatal case of VOD during induction therapy for acute lymphoblastic leukemia.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Asparaginase / administration & dosage
  • Asparaginase / adverse effects
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Hepatic Veno-Occlusive Disease / chemically induced*
  • Hepatic Veno-Occlusive Disease / pathology
  • Humans
  • Liver / pathology
  • Marfan Syndrome / drug therapy
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Middle Aged
  • Polydeoxyribonucleotides / administration & dosage
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Fibrinolytic Agents
  • Polydeoxyribonucleotides
  • defibrotide
  • Vincristine
  • Prednisolone
  • Asparaginase
  • Methotrexate
  • Daunorubicin